We have recently demonstrated in a poorly immunogenic (MC38 colon) tumour model, however, that an oncolytic vaccinia virus expressing the T-cell attracting chemokine, CXCL11, can attract effector cells into the TME and induce specific systemic anti-tumour immunity18. The gene discussed is CXCL11; the disease is neoplasm.